Related Experiment Videos
[Progressive supranuclear ophthalmoplegia (Steele-Richardson-Olszewski)]
Zhurnal Nevropatologii I Psikhiatrii Imeni S.S. Korsakova (Moscow, Russia : 1952)
|January 1, 1984
Summary
This study clarifies the causes and brain damage locations in progressive supranuclear ophthalmoplegia (PSP). Treatments involving vascular, nootropic, and antisclerotic drugs, plus oxygen barotherapy, are recommended for PSP patients.
Area of Science:
- Neurology
- Neuroscience
Background:
- Progressive supranuclear ophthalmoplegia (PSP) is a rare neurodegenerative disease.
- Understanding its pathogenesis and brain lesion localization is crucial for effective management.
Observation:
- Neurological examinations, including pneumoencephalography, rheoencephalography, and computed tomography (CT), were performed.
- Neuropsychological tests were utilized to assess cognitive functions.
- Literature data on PSP was comprehensively analyzed.
Findings:
- The study refined the understanding of the pathogenesis of major PSP manifestations.
- Specific cerebral structures affected in PSP were identified.
- The effectiveness of certain therapeutic interventions was evaluated.
Implications:
- This research aids in precisely diagnosing PSP by pinpointing brain damage.
- Recommended treatments include vascular, nootropic, and antisclerotic drugs.
- Oxygen barotherapy is suggested as a beneficial adjunctive therapy for PSP.